Login / Signup

Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

Rajat ThawaniMatteo RepettoClare KeddyKatelyn NicholsonKristen JonesKevin NusserCatherine Z BeachGuilherme HaradaAlexander E DrilonMonika A Davare
Published in: NPJ precision oncology (2024)
Keyphrases
  • cell death
  • dna damage
  • reactive oxygen species
  • tyrosine kinase
  • advanced non small cell lung cancer
  • oxidative stress
  • chronic myeloid leukemia
  • young adults
  • childhood cancer